Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -22.156% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCN(CC)CCCN=Cc1c(O)n(CCc2ccc(OC)c(OC)c2)c(=O)[nH]c1=O
(b) COC(=O)c1cccc(NC(=O)/C=C/c2ccc3c(c2)OCO3)c1
Answer: b. COC(=O)c1cccc(NC(=O)/C=C/c2ccc3c(c2)OCO3)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1cccc(NC(=O)/C=C/c2ccc3c(c2)OCO3)c1
COC(=O)c1cccc(NC(=O)/C=C/c2ccc3c(c2)OCO3)c1
methyl 3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]benzoate